Impact of lipoprotein (a) on long-term outcome after percutaneous coronary intervention in the era of new generation drug-eluting stents

被引:6
作者
Kimura, Toshio [1 ]
Akahori, Hirokuni [1 ]
Tanaka, Takamasa [1 ]
Yanaka, Koji [1 ]
Yoshihara, Nagataka [1 ]
Miki, Kojiro [1 ]
Imanaka, Takahiro [1 ]
Asakura, Masanori [1 ]
Ishihara, Masaharu [1 ]
机构
[1] Hyogo Coll Med, Dept Cardiovasc & Renal Med, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638131, Japan
关键词
Lipoprotein (a); Coronary artery disease; New generation drug-eluting stems; C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; LDL CHOLESTEROL; VASCULAR RISK; BASE-LINE; RESTENOSIS; METAANALYSIS; PROGNOSIS; INTEGRITY; EFFICACY;
D O I
10.1016/j.jjcc.2022.03.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: High lipoprotein (a) [Lp (a)] levels are associated with worse long-term outcomes in patients undergoing percutaneous coronary intervention (PCI). However, there are limited studies investigating association between Lp (a) levels and long-term outcomes in the era of new generation drug-eluting stents (DES). Methods: A total of 495 patients with available data on Lp (a) who underwent PCI for de novo lesions with new generation DES were enrolled between 2013 and 2017. The primary endpoint was the major adverse cardiovascular event (MACE), which was defined as a composite of cardiac death, myocardial infarction, stent thrombosis, clinically driven target lesion revascularization, and revascularization for new lesions during 3 years. Patients were divided into 2 groups according to the Lp (a) level: high Lp (a) group (>= 30 mg/dL: n= 109) and low Lp (a) group (30 mg/dL>: n = 386). Multivariate Cox regression analysis was performed to identify the predictors for 3-year MACE. Results: The incidence of 3-year MACE was significantly higher in high Lp (a) group than low Lp (a) group (33.0% vs. 15.9%, p < 0.001). Multivariable analysis showed that Lp (a) level of >= 30 mg/dL was an independent predictor for 3-year MACE (HR 2.01, 95%CI 1.30-3.11, p = 0.002). Conclusion: High Lp (a) level was associated with worse long-term outcome even in the era of new generation DES. (C) 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 32 条
[1]  
Alagona Peter Jr, 2009, Am J Manag Care, V15, pS65
[2]   The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor [J].
Argraves, KM ;
Kozarsky, KF ;
Fallon, JT ;
Harpel, PC ;
Strickland, DK .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2170-2181
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials [J].
Boekholdt, S. Matthijs ;
Hovingh, G. Kees ;
Mora, Samia ;
Arsenault, Benoit J. ;
Amarenco, Pierre ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Waters, David D. ;
DeMicco, David A. ;
Simes, R. John ;
Keech, Antony C. ;
Colquhoun, David ;
Hitman, Graham A. ;
Betteridge, John ;
Clearfield, Michael B. ;
Downs, John R. ;
Colhoun, Helen M. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Grundy, Scott M. ;
Kastelein, John J. P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (05) :485-494
[5]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[6]   ELEVATED SERUM LIPOPROTEIN(A) IS A RISK FACTOR FOR CLINICAL RECURRENCE AFTER CORONARY BALLOON ANGIOPLASTY [J].
DESMARAIS, RL ;
SAREMBOCK, IJ ;
AYERS, CR ;
VERNON, SM ;
POWERS, ER ;
GIMPLE, LW .
CIRCULATION, 1995, 91 (05) :1403-1409
[7]   Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults [J].
Emdin, Connor A. ;
Anderson, Simon G. ;
Callender, Thomas ;
Conrad, Nathalie ;
Salimi-Khorshidi, Gholamreza ;
Mohseni, Hamid ;
Woodward, Mark ;
Rahimi, Kazem .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
[8]   PROLIFERATION OF HUMAN SMOOTH-MUSCLE CELLS PROMOTED BY LIPOPROTEIN(A) [J].
GRAINGER, DJ ;
KIRSCHENLOHR, HL ;
METCALFE, JC ;
WEISSBERG, PL ;
WADE, DP ;
LAWN, RM .
SCIENCE, 1993, 260 (5114) :1655-1658
[9]   Acute and chronic tissue response to coronary stent implantation:: Pathologic findings in human specimen [J].
Grewe, PH ;
Deneke, T ;
Machraoui, A ;
Barmeyer, J ;
Müller, KM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :157-163
[10]   Patterns and mechanisms of in-stent restenosis - A serial intravascular ultrasound study [J].
Hoffmann, R ;
Mintz, GS ;
Dussaillant, GR ;
Popma, JJ ;
Pichard, AD ;
Satler, LF ;
Kent, KM ;
Griffin, J ;
Leon, MB .
CIRCULATION, 1996, 94 (06) :1247-1254